Carpentier I - Search Results

1

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R. Verstrepen L, et al. Among authors: carpentier i. Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Biochem Pharmacol. 2009. PMID: 19464428 Review.

2

Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.

Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R. Verstrepen L, et al. Among authors: carpentier i. J Cell Mol Med. 2008 Jan-Feb;12(1):316-29. doi: 10.1111/j.1582-4934.2007.00187.x. Epub 2007 Dec 10. J Cell Mol Med. 2008. PMID: 18081698 Free PMC article.

3

A20: central gatekeeper in inflammation and immunity.

Coornaert B, Carpentier I, Beyaert R. Coornaert B, et al. Among authors: carpentier i. J Biol Chem. 2009 Mar 27;284(13):8217-21. doi: 10.1074/jbc.R800032200. Epub 2008 Nov 13. J Biol Chem. 2009. PMID: 19008218 Free PMC article. Review.

4

Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation.

Verhelst K, Verstrepen L, Coornaert B, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: carpentier i. Methods Mol Biol. 2009;517:205-15. doi: 10.1007/978-1-59745-541-1_13. Methods Mol Biol. 2009. PMID: 19378032

5

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R. Verstrepen L, et al. Among authors: carpentier i. Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Biochem Pharmacol. 2010. PMID: 20599425 Review.

6

TAX1BP1, a ubiquitin-binding adaptor protein in innate immunity and beyond.

Verstrepen L, Verhelst K, Carpentier I, Beyaert R. Verstrepen L, et al. Among authors: carpentier i. Trends Biochem Sci. 2011 Jul;36(7):347-54. doi: 10.1016/j.tibs.2011.03.004. Epub 2011 May 4. Trends Biochem Sci. 2011. PMID: 21546252 Review.

7

Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not.

Verhelst K, Verstrepen L, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: carpentier i. Biochem Pharmacol. 2011 Nov 1;82(9):1057-65. doi: 10.1016/j.bcp.2011.07.066. Epub 2011 Jul 20. Biochem Pharmacol. 2011. PMID: 21787758

8

Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events.

Verhelst K, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: carpentier i. Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):277-86. doi: 10.1016/j.cytogfr.2011.11.002. Epub 2011 Nov 25. Cytokine Growth Factor Rev. 2011. PMID: 22119011 Review.

9

A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.

Verhelst K, Carpentier I, Kreike M, Meloni L, Verstrepen L, Kensche T, Dikic I, Beyaert R. Verhelst K, et al. Among authors: carpentier i. EMBO J. 2012 Oct 3;31(19):3845-55. doi: 10.1038/emboj.2012.240. Epub 2012 Aug 28. EMBO J. 2012. PMID: 23032186 Free PMC article.

10

IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer.

Verhelst K, Verstrepen L, Carpentier I, Beyaert R. Verhelst K, et al. Among authors: carpentier i. Biochem Pharmacol. 2013 Apr 1;85(7):873-80. doi: 10.1016/j.bcp.2013.01.007. Epub 2013 Jan 17. Biochem Pharmacol. 2013. PMID: 23333767 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page